RevOpsis says it is committed to the rapid discovery and development of novel multispecific therapies utilizing its modular ...

Researchers suggest "one daring idea" would be to apply the concept of habituation to the relationship between cancer and immunity.

Abzena's goal is to help customers optimize drug development strategies, secure funding, and navigate regulatory pathways more effectively.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine. The findings ...